NCT05722938: An ongoing trial by Biotest
This trial is ongoing. It must report results 3 years, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05722938 |
|---|---|
| Title | A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With Severe Community-acquired Pneumonia (sCAP) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 9, 2023 |
| Completion date | July 31, 2028 |
| Required reporting date | July 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |